Table of Contents

company-logo

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma. The company is headquartered in Agoura Hills, California.

Oncotelic Therapeutics Dividend Announcement

• Oncotelic Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Oncotelic Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Oncotelic Therapeutics Dividend History

Oncotelic Therapeutics Dividend Yield

Oncotelic Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Oncotelic Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Oncotelic Therapeutics Financial Ratios

P/E ratio-2.78
PEG ratio0.74
P/B ratio1.46
ROE-41.44%
Payout ratio0.00%
Current ratio0.01
Quick ratio0.01
Cash Ratio0.01

Oncotelic Therapeutics Dividend FAQ

Does Oncotelic Therapeutics stock pay dividends?
Oncotelic Therapeutics does not currently pay dividends to its shareholders.
Has Oncotelic Therapeutics ever paid a dividend?
No, Oncotelic Therapeutics has no a history of paying dividends to its shareholders. Oncotelic Therapeutics is not known for its dividend payments.
Why doesn't Oncotelic Therapeutics pay dividends?
There are several potential reasons why Oncotelic Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Oncotelic Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Oncotelic Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Oncotelic Therapeutics a dividend aristocrat?
Oncotelic Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Oncotelic Therapeutics a dividend king?
Oncotelic Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Oncotelic Therapeutics a dividend stock?
No, Oncotelic Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Oncotelic Therapeutics stocks?
To buy Oncotelic Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Oncotelic Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.